Coracten is often a dihydropyridine calcium-channel blocker and is particularly contraindicated in patients with acknowledged really serious dihydropyridine hypersensitivity.Nifedipine can be used in combination with beta-blocking medicines along with other antihypertensive agents, but the potential of an additive result resulting in postural hypot